{
  "report_rows": [
    {
      "kpi": "Revenue",
      "prediction": "BEAT",
      "answer": "pred ~$1.092B vs. cons $1.077B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Non-GAAP EPS",
      "prediction": "BEAT",
      "answer": "pred ~$0.64 vs. cons $0.60",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Billings",
      "prediction": "BEAT",
      "answer": "pred ~$1.145B vs. cons $1.120B",
      "confidence": "LOW"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 revenue guidance",
      "prediction": "LOWER",
      "answer": "guide ~$4.40B vs. cons $4.41B (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q3 2026 revenue guidance",
      "prediction": "LOWER",
      "answer": "guide ~$1.175B vs. cons $1.180B (Q3 2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 non-GAAP operating-income guidance",
      "prediction": "LOWER",
      "answer": "guide ~$975M vs. cons $986M (FY2026)",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": -7,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -10,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "Q2 revenue/EPS and billings beat, but FY2026 guide ~$4.40B versus ~$4.41B consensus implies ~$2.30B of second-half revenue versus ~$2.33B embedded in estimates; the ~$30M out-period shortfall should drive downward revisions after the initial reaction.",
  "day5_confidence": "MEDIUM"
}